Skip To Main Content
Určeno pro odbornou veřejnost
Campus
Campus
View Full Results

Transplantační medicína

Nejnovější trendy

Prozkoumejte nejčtenější články a videa na Campus Sanofi

Seřadit
Recommendations on treatment simplification of complex insulin regimens to improve clinical outcomes in patients with T2DM

Recommendations on treatment simplification of complex insulin regimens to improve clinical outcomes in patients with T2DM

Číst více
Recommendations on treatment simplification of complex insulin regimens to improve clinical outcomes in patients with T2DM

Recommendations on treatment simplification of complex insulin regimens to improve clinical outcomes in patients with T2DM

Číst více
Recommendations on treatment simplification of complex insulin regimens to improve clinical outcomes in patients with T2DM

Recommendations on treatment simplification of complex insulin regimens to improve clinical outcomes in patients with T2DM

Číst více
Recommendations on treatment simplification of complex insulin regimens to improve clinical outcomes in patients with T2DM

Recommendations on treatment simplification of complex insulin regimens to improve clinical outcomes in patients with T2DM

Číst více
Recommendations on treatment simplification of complex insulin regimens to improve clinical outcomes in patients with T2DM

Recommendations on treatment simplification of complex insulin regimens to improve clinical outcomes in patients with T2DM

Číst více
Odyssey outcomes

Odyssey outcomes

Číst více
Odyssey outcomes

Odyssey outcomes

Číst více
Odyssey outcomes

Odyssey outcomes

Číst více
Odyssey outcomes

Odyssey outcomes

Číst více
Safety profile of preoperative administration of low-molecular-weight heparin for Lung Cancer population

Safety profile of preoperative administration of low-molecular-weight heparin for Lung Cancer population

Číst více
Safety profile of preoperative administration of low-molecular-weight heparin for Lung Cancer population

Safety profile of preoperative administration of low-molecular-weight heparin for Lung Cancer population

This randomized clinical trial demonstrated that preoperative administration of low-molecular-weight-heparin (LMWH) is safe and feasible for lung cancer patients preparing to receive minimally invasive surgery.

Číst více
Safety profile of preoperative administration of low-molecular-weight heparin for Lung Cancer population

Safety profile of preoperative administration of low-molecular-weight heparin for Lung Cancer population

This randomized clinical trial demonstrated that preoperative administration of low-molecular-weight-heparin (LMWH) is safe and feasible for lung cancer patients preparing to receive minimally invasive surgery.

Číst více